The transcription factor NF-kappa B plays a critical role in the inflammatory response and it has been implicated in various diseases, including non-alcoholic fatty liver disease (NAFLD). Although transient NF-kappa B activation may protect tissues from stress, a prolonged NF-kappa B activation can have a detrimental effect on tissue homeostasis and therefore accurate termination is crucial. (Co) under bar pper Metabolism (M) under bar URR1 (D) under bar omain-containing 1 (COMMD1), a protein with functions in multiple pathways, has been shown to suppress NF-kappa B activity. However, its action in controlling liver inflammation has not yet been investigated. To determine the cell-type-specific contribution of Commd1 to liver inflammation, we used hepatocyte and myeloid-specific Commd1-deficient mice. We also used a mouse model of NAFLD to study low-grade chronic liver inflammation: we fed the mice a high fat, high cholesterol (HFC) diet, which results in hepatic lipid accumulation accompanied by liver inflammation. Depletion of hepatocyte Commd1 resulted in elevated levels of the NF-kappa B transactivation subunit p65 (RelA) but, surprisingly, the level of liver inflammation was not aggravated. In contrast, deficiency of myeloid Commd1 exacerbated diet-induced liver inflammation. Unexpectedly we observed that hepatic and myeloid Commd1 deficiency in the mice both augmented hepatic lipid accumulation. The elevated levels of proinflammatory cytokines in myeloid Commd1-deficient mice might be responsible for the increased level of steatosis. This increase was not seen in hepatocyte Commd1-deficient mice, in which increased lipid accumulation appeared to be independent of inflammation. Our mouse models demonstrate a cell-type-specific role for Commd1 in suppressing liver inflammation and in the progression of NAFLD. (C) 2014 Elsevier B.V. All rights reserved.
|Number of pages||9|
|Journal||Biochimica et biophysica acta-Molecular basis of disease|
|Publication status||Published - Nov-2014|
- NF-kappa B inhibitor
- EPITHELIAL SODIUM-CHANNEL
- NONALCOHOLIC STEATOHEPATITIS